Study reports serious side effects from AZ drug
AstraZeneca's experimental thyroid cancer drug vandetanib was linked to serious side effects in 31 percent of patients who participated in a recent study, according to the US Food and Drug Administration, which is reviewing the drug for approval.

Read more on The News Journal




Orignal From: Study reports serious side effects from AZ drug

0 评论